Black cohosh: a cause of abnormal postmenopausal liver function tests

References

• Royal College of Obstetricians and Gynaecologists. Menopause and hormone replacement: study group recommendations. http://www.rcog. org.uk/index.asp?PageID=310. 2004 Dec
   Google Scholar
• British Menopause Society Consensus Statements: Alternative and complementary therapies. http://www.thebms.org.uk/statement content.php?id=2
   Google Scholar
• Medicines and Healthcare products Regulatory Agency. Press release: MHRA action on safety concerns over black cohosh and liver injury. http://www.mhra.gov.uk/home/idcplg?IdcService= SS_GET_PAGE&ssDocName=CON2024116&ss SourceNodeId=663&ssTargetNodeId=389
   Google Scholar
• Wuttke W, Raus K, Gorkow C. Efficacy and tolerability of the black cohosh (Actaea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogens-controlled study. Maturitas 2006; 55(Suppl 1)S83–S91
   Google Scholar
• Seidlova-Wuttke D, Thelen P, Wuttke W. Inhibitory effects of a black cohosh (Cimicifuga racemosa) extract on prostate cancer. Planta Med 2006; 72: 521–526
   PubMed Web of Science ®Google Scholar
• Wuttke W, Rimoldi G, Christoffel J, Seidlova-Wuttke D. Plant extracts for the treatment of menopausal women: Safe?. Maturitas 2006; 55(Suppl 1)S92–S100
   Google Scholar
• Burdette J E, Liu J, Chen S N, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003; 51: 5661–5670
   PubMed Web of Science ®Google Scholar
• Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 2003; 44(Suppl 1)S31–S38
   PubMed Web of Science ®Google Scholar
• Fabricant D S, Nikolic D, Lankin D C, et al. Cimipronidine, a cyclic guanidine alkaloid from Cimicifuga racemosa. J Nat Prod 2005; 68: 1266–1270
   PubMed Web of Science ®Google Scholar
• Woo K C, Park Y S, Jun D J, et al. Phytoestrogen cimicifugoside-mediated inhibition of catecholamine secretion by blocking nicotinic acetylcholine receptor in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 2004; 309: 641–649
   PubMed Web of Science ®Google Scholar
• Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin H H. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005; 105: 1074–1083
   PubMed Web of Science ®Google Scholar
• Newton K M, Reed S D, LaCroix A Z, Grothaus L C, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006; 145: 869–879
   PubMed Web of Science ®Google Scholar
• Pockaj B A, Gallagher J G, Loprinzi C L, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG trial N01CC1. J Clin Oncol 2006; 24: 2836–2841
   PubMed Web of Science ®Google Scholar
• Nedrow A, Miller J, Walker M, Nygren P, Huffman L H, Nelson H D. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006; 166: 1453–1465
   PubMed Web of Science ®Google Scholar
• Reed S D, Newton K M, Lacroix A Z, Grothaus L C, Grieco V S, Ehrlich K. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: The Herbal Alternatives for Menopause (HALT) study. Menopause 2007, July 6, Epub ahead of print
   Google Scholar
• Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 2007; 276: 463–469
   PubMedGoogle Scholar
• Whiting P W, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002; 177: 440–443
   PubMed Web of Science ®Google Scholar
• Lynch C R, Folkers M E, Hutson W R. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transplant 2006; 12: 989–992
   PubMed Web of Science ®Google Scholar
• Lontos S, Jones R M, Angus P W, Gow P J. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 2003; 179: 390–391
   PubMed Web of Science ®Google Scholar
• Levitsky J, Alli T A, Wisecarver J, Sorrell M F. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 2005; 50: 538–539
   PubMed Web of Science ®Google Scholar
• Dog T L, Powell K L, Weisman S M. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 2003; 10: 299–313
   PubMed Web of Science ®Google Scholar
• Huntley A. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa). Expert Opin Drug Saf 2004; 3: 615–623
   PubMedGoogle Scholar
• Tsukamoto S, Aburatani M, Ohta T. Isolation of CYP3A4 inhibitors from the black cohosh (Cimicifuga racemosa). Evid Based Complement Alternat Med 2005; 2: 223–226
   PubMed Web of Science ®Google Scholar
• Gurley B J, Gardner S F, Hubbard M A, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005; 22: 525–539
   PubMed Web of Science ®Google Scholar
• Gurley B J, Gardner S F, Hubbard M A, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005; 77: 415–426
   PubMed Web of Science ®Google Scholar
• Huntley A. Drug–herb interactions with herbal medicines for menopause. J Br Menopause Soc 2004; 10: 162–165
   PubMedGoogle Scholar
• Herr, S M, Eazard, E, Veronica, S LY. Herb–drug Interaction Handbook2nd edn. Nassau, NY, Church Street Books. 2002
   Google Scholar